(Q35696268)

9 August 2017

1 reference

title

Pharmacological profile and clinical use of moexipril (English)

1 reference

9 August 2017

Steven G Chrysant

1

1 reference

9 August 2017

George S Chrysant

series ordinal

2

1 reference

9 August 2017

publication date

1 September 2003

1 reference

Expert Review of Cardiovascular Therapy

9 August 2017

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

345-352

1 reference

Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Evidence for site-specific absorption of a novel ACE inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Moexipril. A review of its use in the management of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

The renin-angiotensin system and vascular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Angiotensin receptor blockers: how important is selectivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.345

21 January 2018

Identifiers

DOI

10.1586/14779072.1.3.345

1 reference

release_ny66d23wfjbgdb3qi42yrdd2pm

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ny66d23wfjbgdb3qi42yrdd2pm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference